Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii

被引:82
作者
Romand, S
Chosson, M
Franck, J
Wallon, M
Kieffer, F
Kaiser, K
Dumon, H
Peyron, F
Thulliez, P
Picot, S
机构
[1] Inst Puericulture & Perinatol, Lab Toxoplasmose, F-75014 Paris, France
[2] Hop Croix Rousse, Serv Parasitol, F-69317 Lyon, France
[3] Hop Enfants La Timone, Serv Parasitol, Marseille, France
[4] Hop Edouard Herriot, Serv Parasitol, Lyon, France
关键词
congenital toxoplasmosis; quantitative real-time polymerase chain reaction; prenatal diagnosis; amniotic fluid;
D O I
10.1016/j.ajog.2003.09.039
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Our purpose was to evaluate Toxoplasma gondii concentration in amniotic fluid (AF) samples as a prognostic marker of congenital toxoplasmosis. Study design: A retrospective study was carried out in 88 consecutive AF samples from 86 pregnant women, which were found positive by prospective polymerase chain reaction (PCR) testing. Parasite AF concentrations were estimated by real-time quantitative PCR and analyzed in relation to the clinical outcome of infected fetuses during pregnancy and at birth, taking into account the gestational age at maternal infection. Results: A significant negative linear regression was observed between gestational age at maternal infection and T gondii DNA loads in AF. After adjusting for time at maternal seroconversion by multivariate analysis, higher parasite. concentrations were significantly associated with a severe outcome of congenital infection (odds ratio [OR] = 15.38/log (parasites/mL AF) [95% CI = 2.45-97.7]). Conclusion: PCR quantification of T gondii in AF can be highly contributive for early prognosis of congenital toxoplasmosis. Maternal infections acquired before 20 weeks with a parasite load greater than 100/mL of AF have the highest risk of severe fetal outcome. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:797 / 802
页数:6
相关论文
共 13 条
[1]   DETECTION OF TOXOPLASMA-GONDII BY COMPETITIVE DNA AMPLIFICATION OF BRONCHOALVEOLAR LAVAGE SAMPLES [J].
BRETAGNE, S ;
COSTA, JM ;
VIDAUD, M ;
VANNHIEU, JT ;
FLEURYFEITH, J .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (06) :1585-1588
[2]   Real-time PCR for diagnosis and follow-up of toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes [J].
Costa, JM ;
Pautas, C ;
Ernault, P ;
Foulet, F ;
Cordonnier, C ;
Bretagne, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (08) :2929-2932
[3]  
Costa JM, 2001, PRENATAL DIAG, V21, P85, DOI 10.1002/1097-0223(200102)21:2&lt
[4]  
85::AID-PD18&gt
[5]  
3.0.CO
[6]  
2-1
[7]   Experimental model of congenital toxoplasmosis in guinea-pigs: use of quantitative and qualitative PCR for the study of maternofetal transmission [J].
Flori, P ;
Hafid, J ;
Bourlet, T ;
Raberin, H ;
Genin, C ;
Sung, RTM .
JOURNAL OF MEDICAL MICROBIOLOGY, 2002, 51 (10) :871-878
[8]   Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection [J].
Gouarin, S ;
Gault, E ;
Vabret, A ;
Cointe, D ;
Rozenberg, F ;
Grangeot-Keros, L ;
Barjot, P ;
Garbarg-Chenon, A ;
Lebon, P ;
Freymuth, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (05) :1767-1772
[9]   PRENATAL-DIAGNOSIS OF CONGENITAL TOXOPLASMOSIS WITH A POLYMERASE-CHAIN-REACTION TEST ON AMNIOTIC-FLUID [J].
HOHLFELD, P ;
DAFFOS, F ;
COSTA, JM ;
THULLIEZ, P ;
FORESTIER, F ;
VIDAUD, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (11) :695-699
[10]   Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring [J].
Lebech, M ;
Joynson, DHM ;
Seitz, HM ;
Thulliez, P ;
Gilbert, RE ;
Dutton, GN ;
Ovlisen, B ;
Petersen, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (10) :799-805